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Introduction:This study aimed to estimate the proportion of patients with interstitial cysti-
tis/painful bladder syndrome (IC/BPS) with systemic dysfunction associated co-morbidities
such as irritable bowel syndrome (IBS) and fibromyalgia (FM). Materials and Methods:
Two groups of subjects with IC/BPS were included: (1) physician diagnosed patients with
IC/BPS and (2) subjects meeting NIDDK IC/PBS criteria based on a questionnaire (ODYSA).
These groups were compared to healthy controls matched for age and socio-economic
status. NIDDK criteria required: pain with bladder filling that improves with emptying,
urinary urgency due to discomfort or pain, polyuria >11 times/24 h, and nocturia >2
times/night. The ODYSA instrument evaluates symptoms pertaining to a range of dis-
orders including chronic fatigue, orthostatic intolerance, syncope, IBS, dyspepsia, cyclic
vomiting syndrome, headaches and migraines, sleep, Raynaud’s syndrome, and chronic
aches and pains. Results: IC/BPS was diagnosed in 26 subjects (mean age 47±16 years,
92% females), 58 had symptoms of IC/BPS by NIDDK criteria (mean age 40±17 years,
79% females) and 48 were healthy controls (mean age 31± 14 years, mean age 77%).
Co-morbid complaints in the IC/BPS groups included gastrointestinal symptoms sugges-
tive of IBS and dyspepsia, sleep abnormalities with delayed onset of sleep, feeling poorly
refreshed in the morning, waking up before needed, snoring, severe chronic fatigue and
chronic generalized pain, migraines, and syncope. Discussion: Patients with IC/BPS had
co-morbid central and autonomic nervous system disorders. Our findings mirror those of
others in regard to IBS, symptoms suggestive of FM, chronic pain, and migraine. High
rates of syncope and functional dyspepsia found in the IC/BPS groups merit further study
to determine if IC/BPS is part of a diffuse disorder of central, autonomic, and sensory
processing affecting multiple organs outside the bladder.
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INTRODUCTION
Interstitial cystitis/painful bladder syndrome (IC/BPS) is a syn-
drome characterized by urinary urgency, frequency, nocturia, and
pain in the pelvis that worsens as the bladder fills and improves
with emptying (Clemens et al., 2005; Bogart et al., 2007). IC/BPS
may affect from 0.5 to 12% of women in the US (Jones and
Nyberg, 1997; Clemens et al., 2005) and the quality of life for
patients with interstitial cystitis is significantly degraded (Buffing-
ton, 2004). IC/BPS associates with other disorders such as irritable
bowel syndrome (IBS), Sjogren’s syndrome, fibromyalgia (FM)
syndrome, chronic fatigue syndrome, anxiety disorders, migraines,
and other pain syndromes not related to the bladder. Moreover,
these other conditions frequently precede the onset of bladder
symptoms (Rodriguez et al., 2009; Warren et al., 2009; Hanno et al.,
2010; Nickel et al., 2010). Interestingly, functional gastrointestinal
disorders (FGID) like IBS, which often accompanies IC/BPS, have
similar co-morbid symptoms as IC/BPS (Chelimsky et al., 2012).
Furthermore, IBS harbors co-morbid dysautonomias similar to
chronic fatigue (Wyller et al., 2010; Okamoto et al., 2011), FM
(Reyes del Paso et al., 2011), and migraine headaches (Rashed
et al., 1999). Although still unclear, a common theme to this group
of co-morbid disorders could be related to the autonomic ner-
vous system which connects the nervous system to the end-organ.
Given the frequent co-existence of these disorders, the aim of this
study was to evaluate if a similar number of additional co-morbid
diagnoses that are present in FGID may also be associated with
IC/BPS and contribute to the poor quality of life.
MATERIALS AND METHODS
This cross-sectional IRB-approved review used the Ohio Dysau-
tonomia (ODYSA) questionnaire, a thorough clinical instrument
designed to approximate the diagnosis of several syndromes
that may have associated autonomic dysregulation including:
orthostatic intolerance, reflex syncope, cyclic vomiting syndrome
(CVS), interstitial cystitis, Raynaud’s syndrome, complex regional
pain syndrome (CRPS), IBS, functional dyspepsia, functional
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abdominal pain, migraine headache, FM, and chronic fatigue
syndrome. Where validated, published question-based diagnostic
were utilized directly or slightly modified (Melzack, 1987; Fukuda
et al., 1994; Merskey and Bogduk, 1994; Chelimsky et al., 1995;
Drossman et al., 2000; Sheldon et al., 2002, 2006; Olesen, 2004; Li
et al., 2008; Low and Benarroch, 2008).
All patients who came to the Autonomic Laboratory at Uni-
versity Hospital Case Medical Center for testing for any type of
complaint are asked to complete the ODYSA questionnaire as part
of their clinical care, as well as patients seen in urology, neurology,
rheumatology, and gastroenterology interdisciplinary autonomic
clinics. There were no exclusion criteria.
Control subjects constituted a participant’s same gender friend
or the spouse’s same gender sibling, with intent to closely match
socio-economic and geographic factors. The ODYSA question-
naire includes the O’Leary–Sant question-set (O’Leary and Sant,
1997) as well as a separate face-valid question-set designed to
assess the probability that IC/BPS is present based on most recent
NIDDK (2006) criteria. The probability of having the disease is
forced to 0 or 1 (no intermediate values), and was programmed
into a database (Filemaker) to automatically generate a score for
each subject as the data are entered, obviating any opportunity for
subjective interpretation. Data entry was performed by students
who had no knowledge of patient diagnosis and was double-
checked. NIDDK criteria for IC/BPS were as follows: (1) the
subject’s pain must worsen with a full bladder and improve with
an empty bladder; (2) urinary urgency must result from discom-
fort or pain (not fear of incontinence); (3) and voiding frequency
must exceed 11 times on average in a 24 h period, including at least
twice per night. Each criterion scored 1 if fulfilled and 0 otherwise
with a total possible range of 0–5, and 4 or greater considered likely
IC/BPS.
Three subject groups were used in this study. The first group
included those subjects with a clinical diagnosis (ICDx) of IC/BPS
made by a specialty physician, a urologist, uro-gynecologist, or
gynecologist. The second group comprised subjects with symp-
toms of IC/BPS based on the NIDDK criteria as per ODYSA
question-set (ICSx), and the third group included control sub-
jects enrolled (spouse or friend) who did not meet criteria for
IC/BPS. The exclusion criteria were only established for the con-
trol subjects, in that they could not meet criteria for IC/BPS. We
examined each group for co-morbid disorders using the following
criteria based on question-set answers. The symptoms were sug-
gestive of IBS (periumbilical/lower abdomen abdominal discom-
fort for >6 months with changes in bowel movement frequency
or consistency or relieved by a bowel movement) or for dyspepsia
(discomfort in chest or upper abdomen with one of the follow-
ing: bloating, early satiety, or nausea). For symptoms suggestive
of CVS, the subjects needed to report more than five episodes in
their lifetime of severe stereotypical episodes of nausea or vomiting
with return to baseline health in-between. Dizziness was defined
by reporting one or more of the following symptoms “when you
stand still or exercise a little. . .” one time per day to two times
per week: feel faint, dizzy, lightheaded, or noticed change in vision
or thinking is “off.” For the history of syncope, the question was
phrased as “Do you ever faint (completely lose consciousness)?”
We considered positive if >three times/lifetime. Several questions
were asked about sleep issues:“Does it take more than half an hour
to fall asleep?” (considered delayed onset of sleep if >30 min),“Do
you snore or stop breathing when you sleep?,” “Do you wake up
before you need to?” “Do you force yourself to stay awake during
the day?” (daytime sleepiness), “Do you feel refreshed after you
sleep?”For the fatigue, it was phrased as“Do you have unexplained
severe fatigue lasting. . .,” being considered positive if >6 months.
To have significant headaches, the subjects had to report headaches
>50/lifetime and complain of a throbbing quality and moderate to
severe intensity (migrainous features). To assess for possible Ray-
naud’s syndrome, we asked if the fingers turned white and turned
red in cold temperatures and became painful.
Statistical methods were performed utilizing Microsoft Excel
2010. The Chi-square test was utilized to determine if the individ-
ual co-morbid disorders were different between the two IC/BPS
groups and between each of the IC/BPS groups and the control
group. Statistical significance was considered for p < 0.05.
RESULTS
IC/BPS was diagnosed by a physician in 26 subjects (ICDx group:
mean age 47± 16 years, 92% females), while 58 subjects had symp-
toms of IC/BPS according to NIDDK IC/BPS criteria (ICSx group
mean age 40± 17 years, 79% females), and 48 were healthy con-
trols (mean age 31± 14 years, 77% females). The most common
co-morbid complaints in both IC/BPS groups included gastroin-
testinal symptoms, sleep abnormalities, severe fatigue and chronic
pain, headache, and syncope (Figures 1–4). Orthostatic symptoms
were reported in 74% of ICSx subjects and in 32% of ICDx. Syn-
cope was also more prevalent in the ICSx group (45%) than in
ICDx (24%). This difference in orthostatic symptoms and syn-
cope probably reflects a referral bias, since subjects are frequently
referred to the autonomic laboratory for orthostatic complaints.
The other symptoms were present in the two IC/BPS groups with-
out significant difference. In relation to sleep,both groups reported
taking >30 min to fall asleep (ICDx= 52%; ICSx= 69%), day-
time sleepiness (ICDx= 56%, ICSx= 60%), not feeling refreshed
in the morning (ICDx= 84%; ICSx= 67%), awakening before
needed in the morning (ICDx= 80%; ICSx= 83%), and snor-
ing or stopping breathing at night (ICDx= 40%; ICSx= 43%). In
relation to gastrointestinal symptoms, cyclic vomiting like symp-
toms were uncommon in all IC/BPS groups, but symptoms sug-
gestive of IBS (ICDx= 44%; ICSx= 27%; controls= 12%) and
dyspepsia (ICDx= 40%; ICSx= 43%; controls= 6%) were sig-
nificantly more common in IC/BPS subjects. IC/BPS subjects had
also significantly more complaints of chronic pains lasting longer
than 6 months (ICDx= 57%; ICSx= 91%; controls= 31%) and
fatigue lasting longer than 6 months (ICDx= 53%; ICSx= 53%;
controls= 2%). Interestingly, we could not find a difference
between the two groups and the controls in prevalence of migraine
headaches though power was too low to know if a difference was
truly absent.
DISCUSSION
The present study adds to the list of co-morbid symptom com-
plexes in subjects with IC/BPS, including dyspepsia-like symp-
toms, chronic body-wide pains, and orthostatic complaints. Our
findings support the previously described associations of migraine
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FIGURE 1 | Comparison of effects of IC/BPS on sleep
function between healthy controls and patients diagnosed
by physician or questionnaire. Dx: corresponds to IC/BPS
diagnosed by a physician (diagnosed IC); Sx corresponds to
subjects who have symptoms of IC/BPS based on NIDDK criteria
(symptomatic IC).
FIGURE 2 |This figure summarizes the complaints of fatigue, chronic
pains, and Raynaud’s like symptoms. Dx: corresponds to IC/BPS diagnosed
by a physician (diagnosed IC); Sx corresponds to subjects who have
symptoms of IC/BPS based on NIDDK criteria (symptomatic IC). “Fingers
turning white in cold” is purposed for looking at signs of possible Raynaud’s
syndrome.
headaches, FM, IBS, CRPS, significant sleep abnormalities, and
chronic fatigue (Nickel et al., 2009, 2010; Tsai et al., 2009; War-
ren et al., 2009). These co-morbid symptom complexes probably
contribute to poor quality of life in ways that physicians may
overlook, particularly in a uni-disciplinary context. Importantly,
they also influence our conceptualization of this syndrome as
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FIGURE 3 | Summary of the gastrointestinal complaints. Dx: corresponds
to IC/BPS diagnosed by a physician (diagnosed IC); Sx corresponds to subjects
who have symptoms of IC/BPS based on NIDDK criteria (symptomatic IC).
CVS, cyclic vomiting syndrome; IBS, irritable bowel syndrome.
originating from some type of systemic process, or from a central
nervous system derangement, rather than from the end-organ.
Much of the literature assessing quality of life finds a strong
positive correlation between quality of life and marital status,
sexual function, and employment (Nickel et al., 2007). These
co-morbidities likely contribute to poor quality of life, though
patients themselves may not mention them unless specifically
queried. For this reason, many centers, including ours, now uti-
lize an interdisciplinary clinic with urology-gynecology,neurology,
psychology, anesthesia/pain management, and rehabilitation ser-
vices. Approaches that address sleep, mood, and chronic pain, for
example through the use of a tricyclic agent, and that stress physical
reconditioning through exercise may have specific salutary effects
on the entire syndrome, not just the end-organ that constitutes the
particular focus of the patient’s complaint.
The high frequency of co-morbid disorders well beyond geo-
graphic contiguity with the bladder region (e.g., headache, sleep
disorders, fatigue, etc.) affects our pathophysiologic construct of
IC/BPS, suggesting either some type of systemic disorder, a process
under central nervous system control, or both. The absence of
any frank neuro-inflammation (Nickel, 2002) reduces the likeli-
hood of a disorder of cellular immunity or cytokine activation. An
abnormal central nervous system drive, with secondary psycho-
neuro-endocrine-immune dysfunction (Irwin and Cole, 2011)
seems likely, as occurs in FM, where heart rate variability analy-
sis demonstrates a skew toward low sympathetic frequencies with
reduction or even absence of high parasympathetic frequencies
(Staud, 2008). In migraine, an autonomic neuropathy occurs
frequently (Rashed et al., 1999) with a similar skew favoring
sympathetic over parasympathetic activity.
Although no good data yet exist in patients with IC/BPS, stud-
ies in the co-morbid disorder FM have identified several areas of
the brain that are activated with application of pain that are not
activated in healthy individuals. This “pain matrix” is currently
conceptualized as reflecting an afferent processing disorder (Smith
et al., 2011). Since the primary brain abnormality must involve
both afferent pain processing and efferent autonomic process-
ing simultaneously, good candidates include brainstem structures
such as the locus ceruleus or the raphe nuclei. The raphe are partic-
ularly attractive as a hypothetical region of origination since they
are deeply involved in sleep regulation (Monti, 2010) as well as in
the probable generation of migraine headache and associated phe-
nomena (Pringsheim et al., 2003), one of which occurs in many
if not the majority of patients with most functional disorders.
The raphe are also in close proximity to control areas involved in
continence, which include the pons, the periaqueductal gray, the
thalamus, insula, anterior cingulate, and prefrontal cortex (Kavia
et al., 2005).
The patient group diagnosed with IC/BPS (ICDx) was remark-
ably similar to the group identified by questionnaire (ICSx) and
both differed from control subjects. According to the IC Database
study, NIDDK criteria used for ICSx are more restrictive than spe-
cialist opinion (ICDx; Hanno et al., 1999), and this could explain
the higher rate of “other pains,” if they represent a slightly more
severe subgroup. The higher rate of orthostatic disorders in the
ICSx group represents a referral diagnosis bias to the autonomic
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FIGURE 4 | Summary of orthostatic symptoms and headaches. Dx: corresponds to IC/BPS diagnosed by a physician (diagnosed IC); Sx corresponds to
subjects who have symptoms of IC/BPS based on NIDDK criteria (symptomatic IC).
lab and clinic from where this population was drawn. The rate of
migraine in the healthy control group of 50% was higher than
a recent Norwegian study which found a migraine prevalence
of 35% (Vetvik et al., 2010), perhaps due to a young predomi-
nantly female population that matched the experimental groups
in gender, age, and socio-economic status. However, other com-
mon functional disorders like IBS, dyspepsia, aches, and pain, were
not increased in the control population.
This study has several limitations. Whereas the ICDx group was
diagnosed objectively by a physician specializing in interstitial cys-
titis, the ICSx group used a patient survey with its attendant errors,
subject recall-bias, questionnaire fatigue, and misunderstandings
of questions. The highly similar occurrence of co-morbid disor-
ders in both groups is reassuring, as is the fact that many ICDx
subjects did not meet NIDDK criteria on the questionnaire, since
an identical finding occurred with patients in the IC/BPS Data-
base study (Hanno et al., 1999). Finally, moderate patient numbers
could lead to a type II error, finding no difference between groups
when a difference actually exists. A moderate sample size is not
likely to suggest a difference when the truth is that the groups are
identical.
In conclusion, this study demonstrates widespread co-
morbidities in patients with interstitial cystitis, both physician
and questionnaire diagnosed, with very similar findings in the two
groups. Known co-morbid disorders were confirmed, including
migraine headache, IBS, and widespread pain. New co-morbidities
emerged, including dyspepsia-like symptoms and orthostatic
intolerance. The multiple involvement of organ systems far from
the bladder supports the theory that IC/BPS is not a primary blad-
der disorder (Warren et al., 2011), but rather the bladder is one
more organ system involved in a systemic, possibly neurologic
disorder.
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